190 related articles for article (PubMed ID: 20208322)
1. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Richter J; Saif MW
JOP; 2010 Mar; 11(2):139-43. PubMed ID: 20208322
[TBL] [Abstract][Full Text] [Related]
2. The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Merl MY; Li J; Saif MW
JOP; 2010 Mar; 11(2):148-50. PubMed ID: 20208324
[TBL] [Abstract][Full Text] [Related]
3. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
4. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Lazenby JM; Saif MW
JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Li J; Ng J; Allendorf J; Saif MW
JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
[TBL] [Abstract][Full Text] [Related]
6. Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Li J; Merl MY; Saif MW
JOP; 2010 Mar; 11(2):151-3. PubMed ID: 20208325
[TBL] [Abstract][Full Text] [Related]
7. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
[TBL] [Abstract][Full Text] [Related]
8. Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Bussom S; Saif MW
JOP; 2010 Mar; 11(2):128-30. PubMed ID: 20208319
[TBL] [Abstract][Full Text] [Related]
9. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merl MY; Abdelghany O; Li J; Saif MW
JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
[TBL] [Abstract][Full Text] [Related]
10. New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma.
Ahmed WB; Ng J; Wazer DE; Saif MW
JOP; 2012 Jul; 13(4):354-7. PubMed ID: 22797388
[TBL] [Abstract][Full Text] [Related]
11. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
12. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Chang BW; Siccion E; Saif MW
JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
[TBL] [Abstract][Full Text] [Related]
13. Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Richter J; Saif MW
JOP; 2010 Mar; 11(2):144-7. PubMed ID: 20208323
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Bussom S; Saif MW
JOP; 2010 Mar; 11(2):131-4. PubMed ID: 20208320
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced pancreatic adenocarcinoma: update and progress.
Ng J; Zhang C; Gidea-Addeo D; Saif MW
JOP; 2012 Mar; 13(2):155-8. PubMed ID: 22406589
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
[TBL] [Abstract][Full Text] [Related]
17. Management of borderline resectable pancreatic adenocarcinoma.
Jia Y; Wang TJ; Allendorf J; Saif MW
JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
[TBL] [Abstract][Full Text] [Related]
18. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Chang BW; Saif MW
JOP; 2011 Mar; 12(2):101-5. PubMed ID: 21386630
[TBL] [Abstract][Full Text] [Related]
20. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):339-42. PubMed ID: 21737891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]